Zeer GeneDx / intent / genedx

GeneDx

1001-5000 employees·Stamford, Connecticut, United States·genedx.com

Observed, not inferred · updated weekly

Buying intent

109 tracked signals | Top 15 topics are below | Sales and Marketing are carrying most of it.

52signals · 30 days
68topics tracked
54.84%attributed to a team

Attention by team

LinkedIn activity, by team

Where GeneDx's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Artificial Intelligence
Hiring
Precision Medicine
Digital Health
Drug Development
Open Source
Sales
High50% of team Sales to Artificial Intelligence: High, 50% of this team's signals
High42% of team Sales to Hiring: High, 42% of this team's signals
Sales to Precision Medicine: no signal
Low8% of team Sales to Digital Health: Low, 8% of this team's signals
Sales to Drug Development: no signal
Sales to Open Source: no signal
Marketing
Marketing to Artificial Intelligence: no signal
Marketing to Hiring: no signal
Low25% of team Marketing to Precision Medicine: Low, 25% of this team's signals
Medium75% of team Marketing to Digital Health: Medium, 75% of this team's signals
Marketing to Drug Development: no signal
Marketing to Open Source: no signal
Engineering
Engineering to Artificial Intelligence: no signal
Engineering to Hiring: no signal
Engineering to Precision Medicine: no signal
Engineering to Digital Health: no signal
Low100% of team Engineering to Drug Development: Low, 100% of this team's signals
Engineering to Open Source: no signal
Others
High29% of team Others to Artificial Intelligence: High, 29% of this team's signals
Low7% of team Others to Hiring: Low, 7% of this team's signals
Medium21% of team Others to Precision Medicine: Medium, 21% of this team's signals
Others to Digital Health: no signal
Medium21% of team Others to Drug Development: Medium, 21% of this team's signals
Medium21% of team Others to Open Source: Medium, 21% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Artificial Intelligence
LinkedIn
High volume
94%
last
2d ago
Hiring
LinkedIn
Medium volume
94%
last
today
Precision Medicine
LinkedIn
Medium volume
95%
last
9d ago
Digital Health
LinkedIn
Medium volume
98%
last
9d ago
Drug Development
LinkedIn
Medium volume
98%
last
12d ago
Open Source
LinkedIn
Low volume
98%
last
12d ago
MBA Programs
LinkedIn
Low volume
98%
last
12d ago
Health Care
LinkedIn
Low volume
93%
last
2d ago
AI Governance
LinkedIn
Low volume
98%
last
10d ago
Patient Advocacy
LinkedIn
Low volume
98%
last
9d ago
Generative AI
LinkedIn
Low volume
98%
last
10d ago
Business Outcomes
LinkedIn
Low volume
98%
last
10d ago
Agentic AI System
LinkedIn
Low volume
98%
last
12d ago
Career Development
LinkedIn
Low volume
96%
last
9d ago
Business Model
LinkedIn
Low volume
98%
last
12d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at GeneDx

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others9 active
Executiveresearching Drug Development
in
Directorresearching Precision Medicine
in
Directorresearching Open Source
in
VPresearching Health Care
in
Leadershipresearching Artificial Intelligence
in
researching Artificial Intelligence
in
Executiveresearching Patient Advocacy
in
researching Precision Medicine
in
Sales4 active
Directorresearching Artificial Intelligence
in
Program Director, Revenue Cycle Management
Directorresearching Hiring
in
business development executive
researching Business Development
in
regional account executive
researching Property Management
in
+ 3 more in Sales
Marketing2 active
Head of Growth Marketing
researching Digital Health
in
Senior Director of Corporate Communications
researching Patient Advocacy
in
+ 2 more in Marketing
Support1 active
SVP, Infrastructure
Leadershipresearching Laser Printers
in
+ 1 more in Support
Engineering1 active
Senior Business Developer, Biopharma Partnerships
researching Drug Development
in
+ 1 more in Engineering
Product1 active
Product Lead - Clinical Indications
researching Genomics
in
+ 1 more in Product

See everyone, not just the first 10

18 people across every department at GeneDx, plus a LinkedIn profile link for each.

Primary products / business lines

LinkedIn company profile

We see a world where every genetic condition is understood, and every patient receives the care they need to live their healthiest life through genomics. ​ GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity™, the world’s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx’s ExomeDx™ and GenomeDx™ tests – ranked #1 by ex

New capability sought

Employee posts (LinkedIn)

Business Model; Career Development; Clinical Trials; Digital Health; Drug Development; MBA Programs; Patient Advocacy

Top accounts researching GeneDx

names withheld on the public page

These are companies whose own people brought up GeneDx unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

129,094 companies · 649,540 people are researching Artificial Intelligence

GeneDx's own team shows 10 signals on this topic. No one outside GeneDx has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Hiring66,174 cos · 318,882 people
  • Precision Medicine1,145 cos · 3,537 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching GeneDx.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Sales — 4 people; Leadership — 2 people; Engineering — 2 people; Marketing — 1 person; HR / Talent — 1 person; Product — 1 person; IT — 1 person

What's been said

public posts mentioning GeneDx

Up to 9 public excerpts naming GeneDx from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.

LinkedIn

👋👋👋 #ISPORAnnual ! GeneDx is excited to be here. Come and see us at booth #837! We will show you GeneDx Infinity, one of the world’s largest genomic datasets. With Andrew Pollock, PhD , Sindhu Raghunandan, PhD , Colleen Caleshu MSc, LCGC, PhD Candidate , Jessica Merritt , Susan Williams , Amanda Ventrella , Bridget Boelter #ISPOR #ISPOR2026

May 2026
LinkedIn

🚀 Excited for #ISPOR2026 Day 2 - stop by booth #837 to learn about GeneDx Infinity, one of the world's largest genomic datasets!

May 2026
LinkedInDigital Health

#NEWS UPDATE: Today, we’re excited to announce new GeneDx Infinity™ data and tools to fuel biopharma drug discovery, accelerate clinical trials, and advance health economics outcomes research (HEOR). GeneDx Infinity is growing rapidly – adding 30% more genomic tests in 2025 than the prior 24 years combined–and each patient tested contributes more data to Infinity, which now includes: • More than 2.5 million genetic tests, including over 1 million exomes and genomes • More than 1.4 billion clinical datapoints, including clinical notes • More than 8 million mapped phenotypic datapoints • Integrated longitudinal claims data from Komodo Health ’s Research Dataset, spanning 7 years on average and 92% overlap • More than 1.5 million contactable patients, representative of the US News link ⬇️ Stop by our booth #837 for a demo at ISPOR—The Professional Society for Health Economics and Outcomes Research . I'd love to meet you. #ISPORAnnual #ISPOR2026 #RWD #genomics #HEOR

May 2026
LinkedIn

Looking forward to the ISPOR—The Professional Society for Health Economics and Outcomes Research event in Philadelphia next week! Visit the GeneDx team at booth #837 - I'd love to meet you and show you GeneDx Infinity, one of the world's largest genomic datasets, in action. If you're a biopharma or biotech company interested in advancing drug discovery, accelerating clinical trials, or advancing HEOR research, we'd love to meet and discuss how we can help you quickly and efficiently reach your goals. The power of 2.5M genetic tests + 8M mapped phenotypic datapoints + claims deliver an unprecedented opportunity for human genetics to enable actionable discoveries and precision medicine at speed and scale. #ISPORAnnual #ISPOR #GeneDx #precisionmedicine

May 2026
LinkedIn

Important #raredisease technical paper from Joseph Devaney , Britt Johnson, PhD, FACMG , Mike Bamshad, and colleagues at GeneDx and Seattle Children's assessing the use of PacBio HiFi #longread genome sequencing using real-world patient clinical samples. Very high yield (99.6%) across a variety of diagnostically important alterations, with the only 2 'misses' being in the context of mosaicism. Favorable turn around time and low need for supplementary assays, but still work to be done with throughput and COGS.

May 2026
LinkedIn

Hello from the American Academy of Neurology in Chicago! It’s been a great meeting so far! So many people doing meaningful work to help their patients get answers. The passion across neurology to push diagnostics forward, especially through genetics, is real, and it’s exciting to be part of those conversations. 🧬 🧬 🧬 Great few days with this crew. Come see us at Booth 2229! #AAN #Neurology GeneDx Kathi Gaffney Andrew Bates

Apr 2026
LinkedIn

Wrapping up a full week in NYC with gratitude and high energy. A GeneDx leadership team meeting, a board meeting, presenting at the Komodo Summit with Komodo Health , and yesterday - attending the CNBC Changemaker event, hosted by Julia Boorstin . The speaker lineup was incredible, and I met many fascinating women across industries. Some of my favorite words of inspiration: 💫 The importance of doing the right thing for the people you serve and leading with honesty and transparency - Jessica Tisch, NYPD Commissioner 💫 Friction is positive. The best teams celebrate diversity of thought. As a leader, hang on to what makes you different - Kara Nortman , Founder Angel City, Monarch Collective 💫 Embrace sliding door moments. They lead to exciting and unexpected opportunities you would have never considered - Amy Howe , CEO of FanDuel 💫 Follow your passion. Take a job that fills your soul - Amy Sheer, EVP, Women's Hockey League 💫 Fun can be fuel. Success doesn't have to be serious - Allison Ellsworth , founder of poppi 💫 What does it mean to live a life of meaning? The goal is to create works of significance and deliver breakthroughs that benefit humanity. Ask “what will be different because I’m here?” Reshema Kemps-Polanco - EVP and Chief Commercial Officer at Novartis 💫 Take a bet on yourself. You are enough. Walk through fear and explore it. Try new things and remember failure is a part of life - Naomi Watts, co-founder and Chief Creative Officer, Stripes Beauty Thanks to the speakers for their inspiration and to CNBC for a fantastic event.

Apr 2026
LinkedIn

Please reach out if you would like to learn more about how GeneDx is supporting BioPharma with patient finding and drug discovery. We have the largest rare disease database. I would be happy to set up a capabilities call!

Apr 2026
LinkedInArtificial Intelligence

This morning I had the opportunity to open the Komodo Summit with the Komodo Health team. It is always inspiring to join others across healthcare and life sciences. Incredible perspectives were shared regarding how real-world data and AI-generated insights can accelerate progress and deliver meaningful patient outcomes. Thanks to Arif Nathoo , CEO and co-founder of Komodo Health, and Web Sun , President and co-founder of Komodo Health for the warm welcome. Thanks to my co-presenter Kari Neidigh , VP of Revenue Enablement, for sharing the stage with me and the wonderful story of her daughter. I enjoyed the talk with Diogo Rau , Chief Information and Digital Officer from Eli Lilly and Company and Rathi Suresh , Head of Analytics, Komodo Health. Diogo shared interesting lessons from his time at Apple and how they translate to his vision at Lilly, along with valuable insights on data quality, governance, and how to accelerate AI. It was my honor to share more about GeneDx Infinity, one of the world's largest genomic datasets. With over 2.5M genetic tests and 1M+ exomes/genomes combined with 8M+ phenotypic data points and claims from Komodo Health, Infinity is deep, representative, and includes the longitudinal journey of patients. Infinity can fuel therapeutic discovery, accelerate clinical trials, and advance research. #genomics #RWD #analytics #raredisease

Apr 2026
Straight from GeneDx: 6 earnings calls and filings read in full. Leadership's own words on the public record — not analyst commentary.

Strategic priorities

Earnings call; SEC filings

Competitive Advantage; Data asset; Sales Cycle; Customer Segments; Take Note (+1 more)

What changed recently

Earnings call; SEC filings

Competitive Advantage; Data asset; Sales Cycle; Customer Segments; Take Note; Revenue Cycle Management Software

About this data. GeneDx (genedx.com). Department attribution is 54.84%; remaining activity is grouped under Others. Updated 2026-09-25T18:00:10.181Z.

Not yet computedPer-team narrative summaries